We actively seek license-in opportunities to enrich our pipeline in our key therapeutic areas.

Under our code of conduct, “challenge, speed, investigation, smile”, we try speedy research and development in fields that other companies do not try. Thanks to this, we have launched at least one new product a year, which has contributed to increased pharmaceutical sales revenues over several years.